Physician profile
Alba Morrow
NPI 1386383271
$1,442.83
in general payments reported to CMS, 2019-2025
18 companies · $615 in 2025
The $615 reported for 2025 was more than what 78% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $168 · 2023: $361 · 2024: $299 · 2025: $615.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,275.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,274.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $178.56 | 2024-2025 | Mounjaro, Zepbound |
| Abbvie INC. | $145.97 | 2024 | |
| Xeris Pharmaceuticals, INC. | $135.00 | 2023 | Gvoke Hypopen |
| Alnylam Pharmaceuticals INC. | $125.00 | 2023 | Onpattro |
| Paratek Pharmaceuticals, INC. | $125.00 | 2022 | |
| Amgen INC. | $119.92 | 2025 | Evenity |
| Tandem Diabetes Care, INC. | $107.74 | 2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Insulet Corporation | $97.31 | 2025 | Omnipod |
| Corcept Therapeutics | $74.18 | 2025 | Korlym |
| Neurelis, INC. | $63.44 | 2023 | Valtoco |
| Almatica Pharma LLC | $54.30 | 2023-2024 | Loreev Xr, Gralise |
| Dexcom, INC. | $44.67 | 2025 | Dexcom G6 Transmitter |
| Biogen, INC. | $43.11 | 2022 | |
| Sequel Med Tech, LLC | $39.63 | 2025 | Twiist |
| Novo Nordisk INC | $27.20 | 2025 | Rybelsus, Ozempic |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ascendis Pharma Endocrinology INC | $23.04 | 2025 | Yorvipath |
| Phadia US INC. | $20.94 | 2025 | Immunocap |
| Acella Pharmaceuticals, LLC | $17.82 | 2025 | NP Thyroid 60 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alba Morrow listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.